New fundraising campaign will catalyze larger, higher-conviction investments to bolster promising T1D programs, leveraging the Fund's strong track-record and management team
Led by a $12 million donation from the Bukhman Foundation, the Fund has already secured more than $60 million of commitments toward its $150+ million goal
BOSTON, Oct. 30, 2025 /PRNewswire/ -- The T1D Fund: A Breakthrough T1D Venture, LLC, an impact investment fund focused on accelerating life-changing solutions to treat, prevent, and ultimately cure type 1 diabetes (T1D), announced the launch of a $150+ million fundraising campaign to expand its capital base and accelerate promising T1D programs. Across its 25+ portfolio companies, ranging from seed to public stage, the Fund invests in companies driving innovation across a spectrum of differentiated T1D approaches.
The Fund's capital-raising efforts have been bolstered by several initial contributions,